No Prescription |
 |
 | ||
|
Canesten Topical Cream Generic Clotrimazole |
|
| ||
No Prescription » Prescription Drugs 3 » Canesten Topical Cream Generic Clotrimazole Canesten topical cream and topical solution are indicated for the topical treatment of the following dermal infections:1. Tinea pedis (athlete's foot) tinea cruris (jock itch) and tinea corporis (ringworm of the trunk and limbs) due to Trichophyton rubrum Trichophyton mentagrophytes Epidermophyton floccosum and Microsporum canis. 2. Candidiasis due to Candida albicans including cutaneous candidiasis onychia (infection of the nail or nail bed) paronychia (infection of the nail fold) external genital candidiasis candida balanitis (Candida in the male genital area) nappy rash. 3. Pityriasis versicolor due to Malassezia furfur. 4. Erythrasma (a chronic skin infection due to the bacterium Corynebacterium minutissimum). Buy Canesten Topical Cream Generic Clotrimazole and other Prescription Drugs 3 products online at Medstore. Buy Online at Medstore - Click Here!
About Canesten Topical Cream Generic Clotrimazole: Product Type: Prescription Drugs 3 Canesten Topical Solution( Generic Clotrimazole ) Canesten Topical Cream (Generic Clotrimazole) Generic Clotrimazole 1%w/v 60gm(3 x 20gm) 1%w/v 50gm 1%w/v 20gm 1%w/v 20mL 1%w/v 60mL(3 x 20mL) Generic Clotrimazole Canesten Topical Cream
View more Prescription Drugs 3 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
